Edgar Filing: BIO-STUFF

bios_10q.htm

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

Mark One

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the period ended June 30, 2010

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File No. 333-1258321

Bio-Stuff (Name of small business issuer in its charter)

Nevada (State or other jurisdiction of incorporation or organization)	pending (I.R.S. Employer Identification No.)

476 Rua da Misericordia, Suite 214, Lisbon, Portugal 1200-273 (Address of principal executive offices)

351 91 865 89 93 (Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:	Name of each exchange on which registered:
None

Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001
(Title of Class)

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X ] No[ ]

Indicate by check mark whether the registrant is a large accelerated filed, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer [ ] Accelerated filer [ ]

Non-accelerated filer [ ] Smaller reporting company [X]

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]

Applicable Only to Issuer Involved in Bankruptcy Proceedings During the Preceding Five Years. N/A

Indicate by checkmark whether the issuer has filed all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes[ ] No[ ]

Applicable Only to Corporate Registrants

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the most practicable date:

Class	Outstanding as of August 4, 2010
Common Stock, $0.001	8,876,100

BIO-STUFF

Form 10-Q

Part 1.	FINANCIAL INFORMATION	4

Item 1.	Financial Statements	4
	Balance Sheets	5
	Statements of Operations	6
	Statements of Cash Flows	7
	Notes to Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	17

Item 4.	Controls and Procedures	18

Part II.	OTHER INFORMATION	19

Item 1.	Legal Proceedings	19

Item 1A.	Risk Factors	19

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19

Item 3.	Defaults Upon Senior Securities	20

Item 4.	Submission of Matters to a Vote of Security Holders	20

Item 5.	Other Information	20

Item 6.	Exhibits	20

PART I

ITEM 1. FINANCIAL STATEMENTS

BIO-STUFF

INTERIM FINANCIAL STATEMENTS

JUNE 30, 2010

(Unaudited)

BIO-STUFF (A Development Stage Enterprise) Index to Financial Statements (Unaudited)


Balance Sheet:
June 30, 2010 and December 31, 2009	F-1

Statements of Operations:
For the three and six months ended June 30, 2010 and 2009	F-2

Statements of Cash Flows:
For the six months ended June 30, 2010 and 2009	F-3

Notes to Financial Statements:
June 30, 2010	F-4

BIO-STUFF (A Development Stage Enterprise) Balance Sheet (Unaudited)

				December 31,
	June 30,			2009
	2010			Audited

ASSETS
Current assets:
Cash	$	1,684		$	1,274
Accounts receivable		-			-
Inventory		-			-
Total current assets		1,684			1,274

Fixed Assets
Furniture and Equipment		-			-
Computer Equipment
Leasehold Improvements
Total Fixed Assets		-			-
Less Accumulated Depreciation
Net Fixed Assets		-			-

Other Assets
Deposits					-
Organizational expenses, net of accumulated amortization		776			893
Total Other Assets		776			893
Total assets	$	2,460		$	2,167

LIABILITIES
Current liabilities:
Accounts payable and accrued expenses	$	-		$	250
Advances from shareholder		7,362			1,180
Total current liabilities		7,362			1,430

Total liabilities		7,362			1,430

STOCKHOLDERS' EQUITY
Common stock, $.001 par value, 100,000,000 authorized,
and 8,876,100 shares issued and outstanding		8,876			8,876
Capital in excess of par value		15,969			15,969
Stock subscription receivable		-			-
Deficit accumulated during the development stage		(29,747	)		(24,108	)
Total stockholders' equity		(4,902	)		737
Total liabilities and stockholders' equity	$	2,460		$	2,167

The accompanying notes are an integral part of these financial statements.

F-1

BIO-STUFF (A Development Stage Enterprise) Statements of Operations (Unaudited)

	Cumulative,
	Inception,
	November 17,			Three months			Three Months			Six Months			Three Months
	2008 Through			Ended			Ended			Ended			Ended
	June 30,			June 30,			June 30,			June 30,			June 30,
	2010			2010			2009			2010			2009

Sales	$	-		$	-								$	-

Cost of Sales		-			-									-

Cost of Sales		-			-									-

General and administrative expenses:
Salaries		-			-									-
Depreciation and Amortization		388			58			58			117			117
Legal and professional fees		23,007			2,377			4,267			6,167			5,103
Demo Expense		3,000						3,000			-			3,000
Other general and administrative		1,357			144			410			211			542
Total operating expenses		27,752			2,579			7,735			6,495			8,762
(Loss) from operations		(27,752	)		(2,579	)		(7,735	)		(6,495	)		(8,762	)

Other income (expense):
Interest Income		-			-									-
Currency gains/(losses)		(1,995	)		(77	)		82			856			(600	)
Interest (expense)		-
(Loss) before taxes		(29,747	)		(2,656	)		82			856			(9,362	)

Provision (credit) for taxes on income		-			-			-			-			-
Net (loss)	$	(29,747	)	$	(2,656	)	$	(7,653	)	$	(5,639	)	$	(9,362	)


Basic earnings (loss) per common share				$	(0.0003	)	$	(0.0009	)	$	(0.0006	)	$	(0.0002	)

Weighted average number of shares outstanding					8,876,100			8,876,100			8,876,100			8,876,100

The accompanying notes are an integral part of these financial statements.

F-2

BIO-STUFF (A Development Stage Enterprise) Statements of Cash Flows (Unaudited)

	Cumulative,
	Inception,
	November 17,
	2008 Through
	June 30,			June 30,			June 30,
	2010			2010			2009

Cash flows from operating activities:
Net (loss)	$	(29,747	)	$	(5,639	)	$	(9,362	)

Adjustments to reconcile net (loss) to cash
provided (used) by developmental stage activities:
Depreciation and Amortization		389			117			116
Change in current assets and liabilities:
Inventory		-			-			-
Deposits		-			-			-
Accounts payable and accrued expenses		-			(250	)		(1,750	)
Net cash flows from operating activities		(29,358	)		(5,772	)		(10,996	)

Cash flows from investing activities:
Purchase of other assets		(1,165	)		-			-
					-			-
Net cash flows from investing activities		(1,165	)		-			-

Cash flows from financing activities:
Proceeds from sale of common stock		24,845						425
Advances from shareholder		7,362			6,182			-

Net cash flows from financing activities		32,207			6,182			425
Net cash flows		1,684			410			(10,571	)

Cash and equivalents, beginning of period		-			1,274			24,336
Cash and equivalents, end of period	$	1,684		$	1,684		$	13,765

Supplemental cash flow disclosures:
Cash paid for interest	$	-		$	-		$	-
Cash paid for income taxes		-			-			-

The accompanying notes are an integral part of these financial statements.

F-3

BIO-STUFF

(A development stage enterprise)

Notes to Financial Statements

June 30, 2010

Note 1 - Organization and summary of significant accounting policies:

Following is a summary of the Company’s organization and significant accounting policies:

Organization and nature of business –Bio-Stuff, (“We,” or “the Company”) is a Nevada corporation incorporated on November 17, 2008. The Company is primarily engaged in the development of the “bio-Ashtray”. BIO-STUFF intends to create a prototype and website to begin marketing the ‘bio-Ashtray” in the spring months of 2009 to beach resorts and public beaches. BIO-STUFF intends to create additional bio-degradable products ranging from plastic cutlery, cups and trash bins that promote easy disposal of waste by individuals enjoying open air events thereafter maintaining a low environmental impact when recycled.

The Company has been in the development stage since its formation and has not yet realized any revenues from its planned operations.

Basis of presentation – Our accounting and reporting policies conform to U.S. generally accepted accounting principles applicable to development stage enterprises. Changes in classification of 2009 amounts have been made to conform to current presentations.

Use of estimates -The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents -For purposes of the statement of cash flows, we consider all cash in banks, money market funds, and certificates of deposit with a maturity of less than three months to be cash equivalents.

Property and Equipment – The Company values its investment in property and equipment at cost less accumulated depreciation. Depreciation is computed primarily by the straight line method over the estimated useful lives of the assets ranging from five to thirty-nine years.

Fair value of financial instruments and derivative financial instruments – We have adopted Accounting Standards Codification regarding Disclosure About Derivative Financial Instruments and Fair Value of Financial Instruments. The carrying amounts of cash, accounts payable, accrued expenses, and other current liabilities approximate fair value because of the short maturity of these items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates. We do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments in the management of foreign exchange, commodity price or interest rate market risks.

F-4

BIO-STUFF

(A development stage enterprise)

Notes to Financial Statements

June 30, 2010

Federal income taxes - Deferred income taxes are reported for timing differences between items of income or expense reported in the financial statements and those reported for income tax purposes in accordance with Accounting Standards Codification regarding Accounting for Income Taxes, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for tax loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred taxes are provided for the estimated future tax effects attributable to temporary differences and carryforwards when realization is more likely than not.

Net income per share of common stock – We have adopted Accounting Standards Codification regarding Earnings per Share, which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings per share of common stock is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. We do not have a complex capital structure requiring the computation of diluted earnings per share.

Note 2 - Uncertainty, going concern:

At March 31, 2010, the Company was engaged in a business and had suffered losses from development stage activities to date. In addition, the Company has minimal operating funds. Although management is currently attempting to identify business opportunities and is seeking additional sources of equity or debt financing, there is no assurance these activities will be successful. Accordingly, we must rely on our officers to perform essential functions without compensation until a business operation can be commenced. No amounts have been recorded in the accompanying financial statements for the value of officers’ services, as it is not considered material.

These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 3 - Federal income tax:

We follow Accounting Standards Codification regarding Accounting for Income Taxes. Deferred income taxes reflect the net effect of (a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income tax reporting purposes, and (b) net operating loss carryforwards. No net provision for refundable Federal income tax has been made in the accompanying statement of loss because no recoverable taxes were paid previously. Similarly, no deferred tax asset attributable to the net operating loss carryforward has been recognized, as it is not deemed likely to be realized.

F-5

BIO-STUFF

(A development stage enterprise)

Notes to Financial Statements

June 30, 2010

The provision for refundable Federal income tax consists of the following:

	2009			2008
Refundable Federal income tax attributable to:
Current operations	$	(19,220	)		(4,888	)
Less, Nondeductible expenses		-0-			-0-
-Less, Change in valuation allowance		19,220			4,888
Net refundable amount		-			-

The cumulative tax effect at the expected rate of 15% of significant items comprising our net deferred tax amount are as follows:

	2009			2008
Deferred tax asset attributable to:
Net operating loss carryover	$	2,883		$	733
Less, Valuation allowance		(2,883	)		(733	)
Net deferred tax asset		-			-

At December 31, 2009, an unused net operating loss carryover approximating $2,883 is available to offset future taxable income; it expires in 2028.

Note 4 – Cumulative sales of stock:

Since its inception, we have issued shares of common stock as follows:

On November 17, 2008, our Directors authorized the issuance of 7,100,000 founder shares at par value of $0.001. These shares are restricted under rule 144 of the Securities Exchange Commission.

On various days in December 2008, our Directors authorized the issuance of 1,776,100 shares of common stock at a price of $0.01 per share as fully paid and non-assessable to the subscriber. These shares are not restricted and are free trading.

Note 5 - New accounting pronouncements:

In May 2008, the Accounting Standards Codification issued 944.20.15, “Accounting for Financial Guarantee Insurance Contracts-and interpretation of Accounting Standards Codification 944.20.05”. Accounting Standards Codification 944.20.15 clarifies how Accounting Standards Codification 944.20.05 applies to financial guarantee insurance contracts, including the recognition and measurement of premium revenue and claims liabilities. This statement also requires expanded disclosures about financial guarantee insurance contracts. Accounting Standards Codification 944.20.15 is effective for fiscal years beginning on or after December 15, 2008, and interim periods within those years. Accounting Standards Codification 944.20.15 has no effect on the Company’s financial position, statements of operations, or cash flows at this time.

F-6

BIO-STUFF

(A development stage enterprise)

Notes to Financial Statements

June 30, 2010

In March 2008, the Accounting Standards Codification issued 815.10.15, Disclosures about Derivative Instruments and Hedging Activities—an amendment of Accounting Standards Codification 815.10.05. This standard requires companies to provide enhanced disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under 815.10.15 and its related interpretations, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. This Statement is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with early application encouraged. The Company has not yet adopted the provisions of Accounting Standards Codification 815.10.15, but does not expect it to have a material impact on its consolidated financial position, results of operations or cash flows.

In December 2007, the Accounting Standards Codification 815.10.65, Noncontrolling Interests in Consolidated Financial Statements—an amendment of Accounting Standards Codification 810.10.65. This statement amends Accounting Standards Codification 810.10.65 to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. It clarifies that a noncontrolling interest in a subsidiary is an ownership interest in the consolidated entity that should be reported as equity in the consolidated financial statements. Before this statement was issued, limited guidance existed for reporting noncontrolling interests. As a result, considerable diversity in practice existed. So-called minority interests were reported in the consolidated statement of financial position as liabilities or in the mezzanine section between liabilities and equity. This statement improves comparability by eliminating that diversity. This statement is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008 (that is, January 1, 2009, for entities with calendar year-ends). Earlier adoption is prohibited. The effective date of this statement is the same as that of the related Accounting Standards Codification 805.10.10 (revised 2007). The Company will adopt this Statement beginning March 1, 2009. It is not believed that this will have an impact on the Company’s consolidated financial position, results of operations or cash flows.

In December 2007, the Accounting Standards Codification, issued Accounting Standards Codification 805.10.10 (revised 2007), Business Combinations.’ This Statement establishes principles and requirements for how the acquirer: (a) recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree; (b) recognizes and measures the goodwill acquired in the business combination or a gain from a bargain purchase; and (c) determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. This statement applies prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. An entity may not apply it before that date. The effective date of this statement is the same as that of the related Accounting Standards Codification 810.10.65, Noncontrolling Interests in Consolidated Financial Statements. The Company will adopt this statement beginning March 1, 2009. It is not believed that this will have an impact on the Company’s consolidated financial position, results of operations or cash flows.

F-7

BIO-STUFF

(A development stage enterprise)

Notes to Financial Statements

June 30, 2010

In February 2007, the Accounting Standards Codification, issued Accounting Standards Codification 810.10.65, The Fair Value Option for Financial Assets and Liabilities—Including an Amendment of Accounting Standards Codification 320.10.05. This standard permits an entity to choose to measure many financial instruments and certain other items at fair value. This option is available to all entities. Most of the provisions in Accounting Standards Codification 810.10.65 are elective; however, an amendment to Accounting Standards Codification 320.10.05 Accounting for Certain Investments in Debt and Equity Securities applies to all entities with available for sale or trading securities. Some requirements apply differently to entities that do not report net income. Accounting Standards Codification 810.10.65 is effective as of the beginning of an entities first fiscal year that begins after November 15, 2007. Early adoption is permitted as of the beginning of the previous fiscal year provided that the entity makes that choice in the first 120 days of that fiscal year and also elects to apply the provisions of SFAS No. 157 Fair Value Measurements. The Company will adopt Accounting Standards Codification 810.10.65 beginning March 1, 2008 and is currently evaluating the potential impact the adoption of this pronouncement will have on its consolidated financial statements.

In September 2006, the Accounting Standards Codification issued Accounting Standards Codification 820.10.05, Fair Value Measurements This statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. This statement applies under other accounting pronouncements that require or permit fair value measurements, the Board having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this statement does not require any new fair value measurements. However, for some entities, the application of this statement will change current practice. This statement is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. Earlier application is encouraged, provided that the reporting entity has not yet issued financial statements for that fiscal year, including financial statements for an interim period within that fiscal year. The Company will adopt this statement March 1, 2008, and it is not believed that this will have an impact on the Company’s consolidated financial position, results of operations or cash flows.

F-8

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

GENERAL

Bio-Stuff was incorporated in the State of Nevada on November 14, 2008. On approximately June 30, 2009, we filed a registration statement on Form S-1 with the Securities and Exchange Commission. The Securities and Exchange Commission declared our registration statement effective as of April 9, 2009. We commencemened trading on the Over-the-Counter Bulletin Board November 12, 2009 under the symbol BIOI.

Please note that throughout this Quarterly Report, and unless otherwise noted, the words "we," "our," "us," the "Company," or "Bio-Stuff," refers to Bio-Stuff.

CURRENT BUSINESS OPERATIONS

We are a design and development company of environmentally friendly waste disposal products for resorts, beaches and open air promotional events using bio-degradable plastics. The “bio-Ashtray” is the first product we created. We launched our website www.biostuff.org in May 2009 and have recently updated the site. We have completed the development of the first prototype of the ‘bio-Ashtray” which was completed in September 2009. The metal mold for production was completed in October 2009.

We have started our initial marketing of the “bio-Ashtray to beach resorts, public beaches and open air event promoters. Promoters of open air events range from beverage, food, sport, automotive and fashion wear companies. We offer advertising print on the bio-Ashtray to customers which gives them inexpensive advertising as well as an environmentally responsible image by keeping beaches and open air venues clean. We further intend to create additional bio-degradable products ranging from plastic cutlery, cups and trash bins that promote easy disposal of waste by individuals enjoying open air events thereafter maintaining a low environmental impact when recycled. Any nature of out-door event could be accompanied by our product, making simple and cheap to prevent large numbers of people polluting the surrounding environment with cigarette butts.

We have begun the process of internationally patenting the “bio-Ashtray”. We are presently in our first stage of growth. This phase is estimated to be completed in the next ten months. During this first stage, we are establishing our corporate existence as a publicly held corporation, raising initial capital, and successfully marketing our “bio-Ashtray”. Contingent on the successful completion of our initial growth stage, we plan to aggressively expand our operation and business by distributing our initial product the “bio-ashtray” and creating additional bio-degradable products for open air events. We have earned no revenues to date.

RESULTS OF OPERATION

	Three Month Period Ended June 30, 2010 and Quarter ended June 30, 2009						For the Period from November 14, 2008 (inception) to June 30, 2010
STATEMENT OF OPERATIONS DATA
Sales		-0-			-0-			-0-
General and Administrative Expenses
Salaries	$	-0-		$	-0-		$	-0-
Depreciation and amortization		58			58			388
Demo Expense		0			3,000			3,000
Legal and professional fees		2,377			4,267			23,007
Other general and administrative		144			410			1,357
Loss From Operations	$	(2,579	)	$	(7,735	)	$	(27,752	)
Other income (expense)
Currency gains/(losses)		(77	)		82			(1,995	)
Net loss	$	(2,656	)	$	(7,653	)	$	(29,747	)

We have incurred losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, the sale of equity or from shareholder loans from our directors.

Three Month Period Ended June 30, 2010 Compared to Quarter Ended June 30, 2009.

Our net loss for the three month period ended June 30, 2010 was ($2,656) compared to a net loss of ($7,653) during quarter ended June 30, 2009. During the three month period ended June 30, 2010 and quarter ended June 30, 2009, we did not generate any revenue.

During the three month period ended June 30, 2010, we incurred general and administrative expenses of approximately $2,579 compared to $7,735 incurred during quarter ended June 30, 2009. These general and administrative expenses incurred during the three month period ended June 30, 2010 consisted of: (i) depreciation and amortization of $58 (2009: $58); (ii) legal and professional fees of $2,377 (2009: $4,267); and (iii) other general and administrative expenses of $144 (2009: $410).

General and administrative expenses incurred during the three month period ended June 30, 2010 compared to quarter ended June 30, 2009 decreased primarily due to a decrease in legal and professional fees, which were associated with the preparation and filing of our registration statement with the Securities and Exchange Commission and a one time charge for Demo Expense of $3,000. General and administrative expenses generally include corporate overhead, financial and administrative contracted services, marketing, and consulting costs.

Our loss from operations during the three month period ended June 30, 2010 was ($2,656) or ($0.0003) per share compared to a loss from operations of ($7,653) or ($0.0009) per share during quarter ended June 30, 2009. The weighted average number of shares outstanding was 8,876,100 for the three month period ended June 30, 2010 compared to 8,876,100 for quarter ended June 30, 2009.

LIQUIDITY AND CAPITAL RESOURCES

As at June 30, 2010

As at the three month period ended June 30, 2010, our current assets were $1,684 and our current liabilities were $7,362, which resulted in a working capital deficit of ($5,678). As at the three month period ended June 30, 2010, current assets were comprised of $1,684 in cash. As at the three month period ended June 30, 2010, current liabilities were comprised of: (i) $0 in accounts payable and accrued expenses; and (ii) $7,362 in advances from shareholders.

As at the three month period ended June 30, 2010, our total assets were $2,460 comprised of: (i) $1,684 in current assets; and (ii) $776 in organizational expenses, net of accumulated amortization. The decrease in total assets during the three month period ended June 30, 2010 from quarter ended June 30, 2009 was primarily due to the decrease in cash.

As at the three month period ended June 30, 2010, our total liabilities were $7,362 consisting entirely of current liabilities. The increase in liabilities during the three month period ended June 30, 2010 from quarter ended June 30, 2009 was primarily due to an increase in advances from shareholder.

Stockholders’ equity decreased from $10,595 for quarter ended June 30, 2009 to stockholders’ equity of ($4,902) for the six month period ended June 30, 2010.

Cash Flows from Operating Activities

We have not generated positive cash flows from operating activities. For the three month period ended June 30, 2010, net cash flows used in operating activities was ($5,772), consisting primarily of a net loss of ($5,639). Net cash flows used in operating activities was changed by: (i) $117in depreciation and amortization; and (ii) ($250) relating to accounts payable and accrued liabilities. For quarter ended June 30, 2009, net cash flows used in operating activities was ($10,996), consisting primarily of a net loss of ($9,362). Net cash flows used in operating activities was changed by: (i) $116 in amortization expense; and (ii) ($1,750) in accounts payable and accrued liabilities

Cash Flows from Investing Activities

For the three month period ended June 30, 2010, net cash flows used in investing activities was ($0). For the quarter ended June 30, 2009, net cash flows used in investing activities was $-0-.

Cash Flows from Financing Activities

We have financed our operations primarily from the issuance of equity and shareholder loans from our directors. For the three month period ended June 30, 2010, net cash flows provided from financing activities was $6,182 compared to $425 for quarter ended June 30, 2009. Cash flows from financing activities for the six month period ended June 30, 2010 consisted of $3,000 in proceeds from advances from shareholder.

We expect that working capital requirements will continue to be funded through a combination of further issuances of securities or from our directors. Our working capital requirements are expected to increase in line with the growth of our business.

PLAN OF OPERATION AND FUNDING

Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and shareholder loans. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) development and marketing of our product; and (ii) working capital. We intend to finance these expenses with further issuances of securities or from shareholder loans from our directors. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

TWELVE MONTH OBJECTIVES bio-Ashtray

Twelve Month Objectives	Anticipated Costs		Time Frame
2. US patent of the bio-Ashtray.	$	15,000	Initiated
3. Initial marketing campaign.	$	35,000	Initiated
4. Inventory.	$	60,000	Build inventory after product sales.
Total costs.	$	110,000

MATERIAL COMMITMENTS

As of the date of this Quarterly Report, we do not have any material commitments.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any significant equipment during the next twelve months.

OFF-BALANCE SHEET ARRANGEMENTS

As of the date of this Quarterly Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

GOING CONCERN

The independent auditors' report accompanying our financial statements contains an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Market risk represents the risk of loss that may impact our financial position, results of operations or cash flows due to adverse change in foreign currency and interest rates.

Exchange Rate

Our reporting currency is United States Dollars (“USD”). The Portugal currency (the Euro Dollar) has been formally pegged to the USD. However, rate fluctuations may have an impact on our consolidated financial reporting. As the Euro Dollar is our functional currency, the fluctuation of exchange rates of the Euro Dollar may have positive or negative impacts on our results of operations. However, since all of our potential sales revenue and expenses will be denominated in the Euro Dollar, the net income effect of appreciation and devaluation of the currency against the US Dollar will be limited to the net operating results attributable to us.

Interest Rate

Interest rates in Portugal are low and stable and inflation is well controlled due to the habit of the population to deposit and save money in the banks (among with other reasons, such as Portugal’s perennial balance of trade surplus. Any potential loans will relate mainly to trade payables and will be mainly short-term. However our debt is likely to rise with the establishment of our product in connection with our expansion and were interest rates to rise at the same time this could become a significant impact on our operating and financing activities.

We have not entered into derivative contracts either to hedge existing risks or for speculative purposes.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

We have performed an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer (CEO)/Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures, (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our management, including our CEO and CFO, concluded that our disclosure controls and procedures were effective as of June 30, 2009 to provide reasonable assurance that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Management’s Annual Report on Internal Control Over Financial reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Under the supervision and with the participation of our management, including our CEO and CFO, we evaluated the effectiveness of our internal control over financial reporting as of June 30, 2009. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework.

This Quarterly Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report on Form 10-Q.

Inherent Limitations on Effectiveness of Controls

We believe that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and our CEO and our CFO have concluded that these controls and procedures are effective at the “reasonable assurance” level.

Changes in internal controls

No significant changes were implemented in our internal controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Audit Committee

Our Board of Directors has not established an audit committee. The respective role of an audit committee has been conducted by our Board of Directors. We are contemplating establishment of an audit committee during fiscal year 2009. When established, the audit committee's primary function will be to provide advice with respect to our financial matters and to assist our Board of Directors in fulfilling its oversight responsibilities regarding finance, accounting, and legal compliance. The audit committee's primary duties and responsibilities will be to: (i) serve as an independent and objective party to monitor our financial reporting process and internal control system; (ii) review and appraise the audit efforts of our independent accountants; (iii) evaluate our quarterly financial performance as well as its compliance with laws and regulations; (iv) oversee management's establishment and enforcement of financial policies and business practices; and (v) provide an open avenue of communication among the independent accountants, management and our Board of Directors.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

ITEM IA. RISK FACTORS

No report required.

ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

No report required.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

No report required.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No report required.

ITEM 5. OTHER INFORMATION

No report required.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

Exhibits:

31.1 Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).

31.2 Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).

32.1 Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIO-STUFF

Dated: August 9, 2010	By: /s/ Joao Prata dos Santos
	Joao Prata dos Santos, President and
	Chief Executive Officer


Dated: August 9, 2010	By: /s/ Joao Prata dos Santos
	Joao Prata dos Santos, Chief Financial
	Officer